Literature DB >> 8623040

Dose related response to clozapine in a state psychiatric hospital population: a naturalistic study.

B J Gordon1, D J Milke.   

Abstract

After noting a striking difference in the dosing practices of two treating psychiatrists, each responsible for the operation of a clozapine unit in a state psychiatric hospital, the authors conducted a retrospective chart review to assess the clinical efficacy of low dose x = 294 mg. per day) versus high dose (x = 525 mg. per day) clozapine treatment for a cohort of 31 inpatients. Levels of psychopathology, behavior, and social functioning were assessed six months pre and during clozapine treatment for 16 patients who received low dose clozapine treatment and 15 patients who received high dose clozapine treatment. Patients on both units demonstrated significant reductions in their levels of psychopathology, improved social functioning and improvement in their behavior following six months clozapine treatment. This naturalistic study suggests that the use of low dose clozapine provides effective treatment for chronic, severely treatment resistant inpatients with schizophrenia or schizo-affective illness, at the same time reducing the potential for significant side effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623040     DOI: 10.1007/bf02244276

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  5 in total

1.  A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period.

Authors:  L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The European experience with use of clozapine.

Authors:  D Naber; H Hippius
Journal:  Hosp Community Psychiatry       Date:  1990-08

3.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

Review 4.  Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects.

Authors:  W W Fleischhacker; M Hummer; M Kurz; I Kurzthaler; J A Lieberman; S Pollack; A Z Safferman; J M Kane
Journal:  J Clin Psychiatry       Date:  1994-09       Impact factor: 4.384

5.  Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years.

Authors:  U Juul Povlsen; U Noring; R Fog; J Gerlach
Journal:  Acta Psychiatr Scand       Date:  1985-02       Impact factor: 6.392

  5 in total
  2 in total

Review 1.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 2.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.